Pharmacists Challenged With Amoxicillin, Adderall Shortages
Drug Topics
NOVEMBER 4, 2022
Shortages are leaving patients in the lurch.
Fri.Nov 04, 2022
503 
The other ‘D’ in DE&I
PharmaVoice
NOVEMBER 4, 2022
How companies can work to include people with disabilities into broader equity aims.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
News Roundup: October 31 to November 4
Drug Topics
NOVEMBER 4, 2022
Your weekly roundup of the latest news from Drug Topics®.
Let’s Not Sugar Coat It: HbA1c is the Imperfect Diabetes Diagnostic
Pharmacy Times
NOVEMBER 4, 2022
When diabetes is uncontrolled, higher percentages of hemoglobin become glycated, which causes elevated HbA1c and glucose levels to rise within the body.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Mitigating Population Risk for COVID-19
Drug Topics
NOVEMBER 4, 2022
Drs Rothholz and Goad discuss population health strategies for COVID-19.
Social Isolation May Be Associated with Worse Outcomes in Heart Failure Patients
Pharmacy Times
NOVEMBER 4, 2022
Among heart failure patients, those who were at risk of social isolation had a worse attitude about advance care planning.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Respiratory Syncytial Virus Infection in the Pediatric Population
Pharmacy Times
NOVEMBER 4, 2022
Infection with RSV can take a variety of forms, ranging from a mild upper respiratory tract infection to severe, life-threatening acute respiratory failure.
Contributing Factors That May Lead to Severe COVID-19 Infection
Drug Topics
NOVEMBER 4, 2022
Experts discuss comorbidities as risk factors for patients developing severe COVID-19 symptoms.
Pfizer, BioNTech report bivalent Covid-19 booster more protective than original vaccine
STAT
NOVEMBER 4, 2022
New data from Pfizer and BioNTech on their bivalent Covid-19 vaccine suggests the updated product may be more protective against more recent Omicron subvariants than the original version of the vaccine, the companies said in a statement released Friday. The companies said the levels of neutralizing antibodies that target the BA.4 and BA.5 subvariants of the SARS-CoV-2 virus were four-fold higher in people aged 55 and older who received the bivalent booster than in similarly aged people who recei
Relationship Between Psoriasis, Kidney Damage Remains Unclear
Pharmacy Times
NOVEMBER 4, 2022
Psoriasis and end-stage renal disease are believed to share multiple pathogenic pathways, including various cytokines, reactive oxygen species, and psoriasis medications.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT+: A ‘blank check’: Bill to boost antibiotic development blasted as a ‘flawed’ giveaway to pharma
STAT
NOVEMBER 4, 2022
Amid mounting concern over antibiotic resistance, a coalition of academics and advocacy groups is urging Congress not to pass legislation to reward drug companies for developing new treatments, because they argue the bill fails to require acceptable clinical trial standards and is tantamount to a giveaway to the pharmaceutical industry. The legislation, known as the Pasteur Act, would encourage drug development by creating a subscription-style business model in which the U.S. government offers u
Expert Suggests That Pharmacists Should Learn More About Dialysis
Pharmacy Times
NOVEMBER 4, 2022
Education, awareness, and more training may help more pharmacists and kidney patients consider home dialysis as an effective treatment option, said an expert on November 4 at ASN Kidney Week in Orlando, Florida.
How doulas could help prevent the harms that can happen during childbirth
STAT
NOVEMBER 4, 2022
When Tamiya Griffin was expecting her first child in 2014, she had what she thought was a straightforward plan: deliver at the hospital down the road, the same place her mother gave birth to her. But when Griffin, then a 22-year-old senior in college, went into labor a few weeks early, she had to undergo an emergency C-section. “And that was not a part of my plan.
Study Links Hormone Therapy With Depression in Women Undergoing Menopause
Pharmacy Times
NOVEMBER 4, 2022
Systemically administered hormonal therapy may be associated with a greater risk of depression before and during menopause.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Opinion: Millions of Americans have health insurance that isn’t ‘good enough’
STAT
NOVEMBER 4, 2022
The open enrollment season for health insurance is gearing up at a time when more people in the United States have health insurance than ever before. Yet millions of Americans who enroll this fall still won’t be able to easily afford the health care they need or will be hit with medical bills they can’t pay. Why? Because whether you have health insurance through an employer, the individual market, or even through Medicare, high health care costs and coverage exclusions are making i
FDA Grants Elranatamab With Breakthrough Therapy Designation for Relapsed or Refractory Multiple Myeloma
Pharmacy Times
NOVEMBER 4, 2022
Elranatamab is a B-cell maturation antigen (BCMA)-CD3-targeted bispecific antibody.
‘Our community is supported at the highest levels’: Adm. Rachel Levine on gender-affirming care
STAT
NOVEMBER 4, 2022
BOSTON — As the health and safety of trans and queer youth are jeopardized across the country, there were a few minutes of hope on Wednesday in Boston when Adm. Rachel Levine , the assistant secretary for health at the Department of Health and Human Services and first transgender federal official confirmed by the U.S. Senate, visited the Boston Alliance of LGBTQ+ Youth.
Psilocybin improves depression symptoms, study shows
European Pharmaceutical Review
NOVEMBER 4, 2022
A new report in the New England Journal of Medicine for the largest-ever trial observing the effects of psilocybin in patients with treatment-resistant depression, found participants reported reduced depressive symptoms three weeks after being given 25mg of psilocybin (COMP360) in combination with psychological support. The multi-centre, Phase IIb trial observed the severity of depression in 233 individuals over 12 weeks in 22 sites and 10 countries across Europe (Czech Republic, Denmark, German
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT+: U.S. Supreme Court gives Amgen a boost by agreeing to review a closely watched patent case
STAT
NOVEMBER 4, 2022
In a boost for Amgen, the U.S. Supreme Court on Friday agreed to hear a case in which the company argued a federal appeals court incorrectly determined its patent claims on a cholesterol medication are invalid. At issue is a long-running battle between Amgen and a pair of rivals — Sanofi and Regeneron Pharmaceuticals — over the market for injectable cholesterol treatments.
First virtual clinical trial examines two promising Alzheimer’s drugs
European Pharmaceutical Review
NOVEMBER 4, 2022
A new computer model has successfully simulated a clinical trial evaluating the efficacy of aducanumab and donanemab for Alzheimer’s disease (AD), establishing a gradual increase in dosage up to the maximum dose helps to minimise cognitive decline and limit side effects. . The US-based researchers modelled personalised treatments for each virtual patient, assessing US Food and Drug Administration-approved aducanumab and donanemab, a therapy currently being evaluated and other potential AD
How Myo-inositol Can Improve Hashimoto’s Symptoms
The Thyroid Pharmacist
NOVEMBER 4, 2022
As an avid researcher, I am always struck by the interrelationship between diseases of the body and the mind. A good example of this that I often observe with Hashimoto’s clients is anxiety, mood swings, and OCD (obsessive-compulsive disorder) symptoms. I see these as clues that a person may be having underlying issues with their thyroid. As a pharmacist, I’ve been frequently dismayed that our modern medical solution to these mind-body connections is to throw completely different prescription me
A letter from the executive editor: STAT turns 7
STAT
NOVEMBER 4, 2022
Dear Readers, Today, STAT turns 7. I’d like to express my gratitude to readers like yourself for being as passionate as we are about what we’ve built: a media company focused single-mindedly on the worlds of health, medicine, and life sciences that now stands at more than 100 employees strong.
Diet Low in Potassium May Not Treat Hyperkalemia, Chronic Kidney Disease
Pharmacy Times
NOVEMBER 4, 2022
Researchers outline new findings about the connection between hyperkalemia and renin-angiotensin-aldosterone system inhibitors during a session at ASN Kidney Week.
STAT+: Up and down the ladder: The latest comings and goings
STAT
NOVEMBER 4, 2022
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.
Expert Suggests Precision Medicine is a Highly Desirable Goal for Dialysis Patients
Pharmacy Times
NOVEMBER 4, 2022
Applying the principles of precision medicine to peritoneal dialysis could improve the flexibility and personalization of care for dialysis patients.
Digital cognitive behaviour therapies recommended by NICE across the NHS
Pharma Times
NOVEMBER 4, 2022
Treatment will assist young people and children with symptoms of mild-to-moderate anxiety
Triplet Regimen With Durvalumab May Increase Overall Survival of Patients with Fatal Intrahepatic Cholangiocarcinoma
Pharmacy Times
NOVEMBER 4, 2022
Promising data suggest triplet regimens may more effectively treat patients with unresected and metastatic intrahepatic cholangiocarcinoma.
Unlocking the full power of data for Pharma
pharmaphorum
NOVEMBER 4, 2022
The value of data has never been greater in healthcare. With greater digital engagement and opportunities available as the world emerges from the COVID-19 pandemic, putting data to use is critical for healthcare and the pharmaceutical industry. In an increasingly digital-first world, the way that HCPs engage with organisations, conduct research, and search for information is changing.
Leva Clinic fundraises £3m for UK’s first digital chronic pain platform
Pharma Times
NOVEMBER 4, 2022
Funding will be used to broaden partnerships with the NHS and improve patient experience
Boehringer recruits former Novartis’ neurosciences head as its CMO
pharmaphorum
NOVEMBER 4, 2022
Boehringer Ingelheim has appointed Lykke Hinsch Gylvin as its new head of medicine and chief medical officer, succeeding Mehdi Shahidi, who left the position earlier this year after three years in the role. Hinsch Gylvin – who joins Boehringer after two years at Novartis, where she was firstly medical head of ophthalmology and latterly medical head of neurosciences – started in the new position on 1 November. “It’s so exciting to be part of this company as we share our passion to del
HDA Research: Pharma Sales via Distributors Make Up 94% of Market
Pharmaceutical Commerce
NOVEMBER 4, 2022
Prescription drugs are the main drivers in this effort.
Addressing the Knowledge Gap in Biologics & Biosimilars: Is a Board Certified Biologics and Biosimilars Program the Answer?
PharmExec
NOVEMBER 4, 2022
Life sciences professionals will need keep up with market demand for biologics and biosimilars.
Critical Gaps: Developing and Optimizing Cleaning Processes
ISPE
NOVEMBER 4, 2022
Critical Gaps: Developing and Optimizing Cleaning Processes. Trudy Patterson. Fri, 11/04/2022 - 13:33. White Paper — Sponsored Content. Critical Gaps: Developing and Optimizing Cleaning Processes. 1 November 2022. Cleaning validation can be among the most painful and time-consuming aspects of GMP manufacturing for pharmaceutical developers, but "more complex" does not always mean "more compliant".
Let's personalize your content